Clinical Trial

A Study of QLP2117 in Combination With QL2107 in Advanced Solid Tumor Patients

Name: A Study of QLP2117 in Combination With QL2107 in Advanced Solid Tumor Patients — clinical trial record (NCT06911827)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

The goal of this clinical trial is to evaluate the safety and efficacy of QLP2117 in combination with QL2107 in Advanced Solid Tumor Patients.

Protocol Amendment History 1 change

notable Enrollment increased: 90 -> 149 participants 2026-04-08

Trial Details

NCT Number	NCT06911827
Lead Sponsor	Qilu Pharmaceutical Co., Ltd.
Conditions	Advanced Solid Tumor
Enrollment	149 participants
Start Date	2025-05-09
Primary Completion	2027-12 (estimated)
Study Completion	2028-12 (estimated)
Updated on ClinicalTrials.gov	2026-04-07